The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies.
about
Novel approach to meta-analysis of microarray datasets reveals muscle remodeling-related drug targets and biomarkers in Duchenne muscular dystrophyBiochemical and Functional Comparisons of mdx and Sgcg(-/-) Muscular Dystrophy Mouse Models.A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping.Application of fluorescence two-dimensional difference in-gel electrophoresis as a proteomic biomarker discovery tool in muscular dystrophy researchLong-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers.The polyproline site in hinge 2 influences the functional capacity of truncated dystrophins.Microarchitecture is severely compromised but motor protein function is preserved in dystrophic mdx skeletal muscle.New pathobiochemical insights into dystrophinopathy from the proteomics of senescent mdx mouse muscleMuscle structure influences utrophin expression in mdx mice.Generation of muscular dystrophy model rats with a CRISPR/Cas system.DNAJB2 expression in normal and diseased human and mouse skeletal muscle.Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.Computational study of the human dystrophin repeats: interaction properties and molecular dynamics.Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients.A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophyHmgb3 is regulated by microRNA-206 during muscle regeneration.Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophyEffects of an immunosuppressive treatment in the GRMD dog model of Duchenne muscular dystrophy.Quadriceps myopathy caused by skeletal muscle-specific ablation of β(cyto)-actinThe miR-206/133b cluster is dispensable for development, survival and regeneration of skeletal muscle.Targeting the activin type IIB receptor to improve muscle mass and function in the mdx mouse model of Duchenne muscular dystrophy.Feline genetics: clinical applications and genetic testing.Adeno-associated viral (AAV) vectors do not efficiently target muscle satellite cellsStem cell transplantation for treating Duchenne muscular dystrophy: A Web of Science-based literature analysisThe FVB Background Does Not Dramatically Alter the Dystrophic Phenotype of Mdx MiceDuchenne muscular dystrophy gene therapy in the canine model.MASTR directs MyoD-dependent satellite cell differentiation during skeletal muscle regenerationGender differences in contractile and passive properties of mdx extensor digitorum longus muscle.Porcine models of muscular dystrophymicroRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice.Focal but reversible diastolic sheet dysfunction reflects regional calcium mishandling in dystrophic mdx mouse hearts.Cardiac Niche Influences the Direct Reprogramming of Canine Fibroblasts into Cardiomyocyte-Like Cells.Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.Proteomics reveals drastic increase of extracellular matrix proteins collagen and dermatopontin in the aged mdx diaphragm model of Duchenne muscular dystrophyAnimal models of muscular dystrophyEmerging strategies for cell and gene therapy of the muscular dystrophiesProlonged Culture of Aligned Skeletal Myotubes on Micromolded Gelatin Hydrogels.Comparative Genomics of X-linked Muscular Dystrophies: The Golden Retriever ModelKinematics of gait in golden retriever muscular dystrophy.Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy
P2860
Q28480452-B0A64B92-359F-4EE5-B1B9-D98AD8C6A268Q30650746-EE686A5A-8534-4AD6-ACDB-AB5FC9C956D0Q33523810-5D20A13E-DAEB-436F-9F22-CE1437CDD1E8Q33565229-17AA2E82-A48D-4EF9-8E21-190A19D68FA3Q33573648-5B882300-1B6D-48E2-96AA-2DA27F019B88Q33587381-41D37243-9EFF-4D03-ADFD-C84DBD4A283CQ33647871-6EB720E5-1A63-4A21-83B0-6A9EE38C1689Q33703934-16C6BA93-A897-45B5-B8BC-2E340AAC079BQ33747602-18B1223C-EA17-4906-BD47-D26F7A16F829Q33868949-527C2C59-008B-4F15-AFDA-79A8CFACA579Q33882517-9FE3E544-4532-40B1-A114-9A164AD72348Q33991780-6F3BC9EC-F033-42E4-88C0-F2FE18F80FE7Q34013751-7D8C0572-F9CC-4849-9174-7C643AFCB802Q34041966-63CA5A12-3B9E-4CF1-BFBC-4B2F5DE6E7D4Q34175938-17D214BC-9CA2-424E-A0D9-F2CDC8C83B8CQ34389648-20E71E2B-81DC-4DBA-A036-3DDC21077742Q34424160-D01B6B81-B0D6-4906-96C4-2E6DB5DCA9F7Q34489678-B6B77D5C-A158-4765-AA0A-1B673D82B68FQ34625134-34548593-B55B-42A9-AD85-C2FABB8F5FFAQ34748864-D8DC4C69-4B94-4AC7-8377-45DB39534579Q34756106-DBF2DC82-91F3-427A-8547-0C9A8695932AQ34777085-D5CD3494-94A3-46D6-8A2F-68DD6DE8EA98Q34886209-33B9B970-1E13-4759-8CF6-047AC4FA83F5Q34997665-EC95BDBB-CFC4-4E95-B9DF-D3239177F34DQ35117470-7843F680-F85B-476E-A69C-C395517E02D1Q35641673-C5CC2C06-E1D5-4136-BE72-C98A6012E60CQ35740619-F3305C09-F1A1-4BA1-84D7-BD5BA34F2775Q35819136-3A917BE6-9BF8-46DE-B8FD-B4E18653590BQ35974809-3F45F399-5CDB-4700-9457-8D1DA12180BEQ36005429-F288F08E-2C66-4081-94F7-8FB530E888C8Q36309327-A595C2E5-629D-4A53-B58A-3B64E06FF901Q36349790-2CF9774D-8BFD-4FC8-966C-9576ECCA7105Q36422465-F7B4B59B-E32F-4F50-936C-1FBB2BA75D97Q36613670-725224C6-9206-4AD7-87FC-526AB1326486Q36915922-CCFEF61F-9D4F-49A1-B8E0-C6C82D0965A2Q36960845-AC70F6F9-5207-40BB-8C27-1FB89A250DE9Q37044962-05BF4E4C-B5C0-4041-AC87-9F0F26E03FF0Q37148808-0090761C-D580-4152-8B8D-1B1320E70442Q37184680-AE23CA02-59B3-439D-A7CD-19F6F8E70E3FQ37196136-E2FFCBAA-C4C1-4D53-815B-34CAC646D6E1
P2860
The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The value of mammalian models ...... loping therapeutic strategies.
@en
The value of mammalian models ...... loping therapeutic strategies.
@nl
type
label
The value of mammalian models ...... loping therapeutic strategies.
@en
The value of mammalian models ...... loping therapeutic strategies.
@nl
prefLabel
The value of mammalian models ...... loping therapeutic strategies.
@en
The value of mammalian models ...... loping therapeutic strategies.
@nl
P1476
The value of mammalian models ...... loping therapeutic strategies.
@en
P2093
Glen B Banks
Jeffrey S Chamberlain
P304
P356
10.1016/S0070-2153(08)00609-1
P577
2008-01-01T00:00:00Z